CB Flock Corporation is a clinical research site located in Mobile, Alabama, United States 36608.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
CB Flock Corporation has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CB Flock Corporation has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CB Flock Corporation has 1 clinical trials on record, with 1 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease.
CB Flock Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.